| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 11/24/1999 | EP0958366A1 Human chemokine beta-13 |
| 11/24/1999 | EP0958361A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 11/24/1999 | EP0958287A1 Sulfamide-metalloprotease inhibitors |
| 11/24/1999 | EP0957936A1 Formulations of recombinant papillomavirus vaccines |
| 11/24/1999 | EP0957930A2 Substance p treatment for immunostimulation |
| 11/24/1999 | EP0957929A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 11/24/1999 | EP0957926A1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 11/24/1999 | EP0957907A1 Il-8 receptor antagonists |
| 11/24/1999 | EP0833653A4 Serum immunoregulatory polypeptides and uses therefor |
| 11/24/1999 | EP0822831B1 Vaccines containing a saponin and a sterol |
| 11/24/1999 | EP0730470A4 Improved interferon polymer conjugates |
| 11/24/1999 | CN1236392A Phsopholipase D and DNA sequences |
| 11/24/1999 | CN1236369A New Knoevenagel condensation products, method for their production and use |
| 11/24/1999 | CN1236354A Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same |
| 11/24/1999 | CN1046731C Pyrrolo [2,3-d] pyrimidines and their use |
| 11/24/1999 | CN1046727C HIV protease inhibitors |
| 11/24/1999 | CN1046715C Process for making HIV protease inhibitors |
| 11/24/1999 | CN1046711C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 11/23/1999 | US5990328 Forming 4-nitro-3-ketosteroids which by nitration of the corresponding 3,5-dienolate, reduction of 4-nitro-3-ketosteroid forms 4-amino-3-ketosteroid |
| 11/23/1999 | US5990314 Pharmaceutical pyridine compounds |
| 11/23/1999 | US5990286 Antibodies with reduced net positive charge |
| 11/23/1999 | US5990282 Receptor protein for human B cell stimulatory factor-2 |
| 11/23/1999 | US5990170 Possesses a profile of activity which is similar to, though less potent than .delta.9-thc (tetrahydrocannabinol) with a mimicking of the psychoactive effects; analgesics; side effect reduction; cardiovascular disorders |
| 11/23/1999 | US5990142 Antiinflammatory agents and antiallergens having good oral adsorption and bioavailability; cardiotonic and antiischemic agents |
| 11/23/1999 | US5990127 Process for the preparation of 4-(4-(4-(hydroxybiphenyl)-1-piperidinyl)-1-hydroxybutyl)-α,α -dimethylphenylacetic acid and phosphorylated derivatives |
| 11/23/1999 | US5990109 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 11/23/1999 | US5990103 Treating psoriasis by topical adminstration of pentoxifylline and diltiazem to a patient; a combination of a compound having a phosphodiesterase-inhibiting action, and a compound which reduces the intracellular calcium content |
| 11/23/1999 | US5990091 First nucleic acid molecule to be expressed, and a second nucleic acid molecule encoding a transcription factor and translation factor, where there is co-temporal expression so expression of the second enhances expression of the first |
| 11/23/1999 | US5990090 A double-stranded dna nf-kappab inhibitor of given nucleotide sequence is effective for the treatment of immune and inflammatory diseases, cancer, and viral infections |
| 11/23/1999 | US5989863 Human ankyrin family protein |
| 11/23/1999 | US5989822 Diagnosis and treatment of cancer, neurodegenerative and autoimmune diseases; gene expression |
| 11/23/1999 | US5989803 Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase |
| 11/23/1999 | US5989564 Pertussis toxoid made by reacting pertussis toxin with the nitrating agent TNM |
| 11/23/1999 | US5989554 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 11/23/1999 | US5989553 Expression library immunization |
| 11/23/1999 | US5989552 Antigen carbohydrate compounds and their use in immunotherapy |
| 11/23/1999 | US5989551 Materials and methods for detection and treatment of insulin-dependent diabetes |
| 11/23/1999 | US5989547 Leptospiral outer membrane proteins |
| 11/23/1999 | US5989546 Interleukin-2 stimulated T lymphocyte cell death for the treatment of allergic responses |
| 11/21/1999 | CA2270687A1 Use of a peptide compound in the treatment of systemic lupus erythematosus |
| 11/18/1999 | WO1999058684A2 Compounds from moraxella catarrhalis |
| 11/18/1999 | WO1999058658A2 Expression vectors for stimulating an immune response and methods of using the same |
| 11/18/1999 | WO1999058642A2 Secreted proteins and polynucleotides encoding them |
| 11/18/1999 | WO1999058572A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 11/18/1999 | WO1999058571A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 11/18/1999 | WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 11/18/1999 | WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 11/18/1999 | WO1999058504A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 11/18/1999 | WO1999058503A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments |
| 11/18/1999 | WO1999058502A1 Heterocyclic inhibitors of p38 |
| 11/18/1999 | WO1999058157A1 Method for inhibiting antibody-mediated rejection of xenogeneic tissues |
| 11/18/1999 | WO1999058153A1 Methods of diagnosing and modulating autoimmunity |
| 11/18/1999 | WO1999058147A1 APOPTOSIS OF NAIVE HUMAN NK CELLS BY CROSSLINKING OF THEIR FcγRIIIa MOLECULES WIHT A RAT IgG2b (LO-CD2a/BTI-322) OR ITS IgG1 HUMANIZED MONOCLONAL ANTIBODY |
| 11/18/1999 | WO1999058146A1 ATTENUATED MUTANTS OF SALMONELLA WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN |
| 11/18/1999 | WO1999058145A2 Immunomodulators for vaccines |
| 11/18/1999 | WO1999058137A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions |
| 11/18/1999 | WO1999058096A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 11/18/1999 | WO1999058095A2 Pharmaceutical and/or cosmetic compositions containing sea water |
| 11/18/1999 | WO1999050285A3 Production methods and uses of a retrovirus |
| 11/18/1999 | WO1999049856A3 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 11/18/1999 | WO1999049855A3 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils |
| 11/18/1999 | WO1999047673A3 Isolated mammalian membrane protein genes and related reagents |
| 11/18/1999 | WO1999047163A3 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 11/18/1999 | WO1999045962A9 Transgenic non-human animals capable of producing heterologous antibodies |
| 11/18/1999 | WO1999042584A9 Apoptosis inducing molecule ii and methods of use |
| 11/18/1999 | WO1999042076A9 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 11/18/1999 | WO1999037682A3 Antibodies against human il-12 |
| 11/18/1999 | WO1999028349A3 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS |
| 11/18/1999 | WO1999027098A3 A-33 related antigens and their pharmacological uses |
| 11/18/1999 | DE19822036A1 Effervescent pharmaceutical composition with improved stability |
| 11/18/1999 | DE19821951A1 Orally administered solid or liquid cyclosporin compositions |
| 11/18/1999 | DE19821925A1 Bacteriophage expression system for production of composition for induction of tumor specific responses |
| 11/18/1999 | DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders |
| 11/18/1999 | DE19821003A1 New dihydro-indazolone derivatives useful as antiasthmatic, antiallergic and neuroprotective agents and for treatment of inflammation and immune disorders |
| 11/18/1999 | DE19821002A1 New indazole derivatives useful as antiasthmatic, antiallergic, neuroprotective agents and for treatment of inflammation and immune disorders |
| 11/18/1999 | CA2685270A1 Expression vectors for stimulating an immune response and methods of using the same |
| 11/18/1999 | CA2332616A1 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and their uses |
| 11/18/1999 | CA2331832A1 E.coli heat-labile enterotoxin subunit b (etxb) as an immunomodulator |
| 11/18/1999 | CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 11/18/1999 | CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 11/18/1999 | CA2328502A1 Cloning of basb020 antigen from moraxella catarrhalis |
| 11/18/1999 | CA2328062A1 Secreted proteins and polynucleotides encoding them |
| 11/18/1999 | CA2288993A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions |
| 11/17/1999 | EP0956865A1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 11/17/1999 | EP0956859A1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 11/17/1999 | EP0956855A1 Immunosuppressive effects of 8-substituted xanthine derivatives |
| 11/17/1999 | EP0956351A1 A tumor necrosis factor related ligand |
| 11/17/1999 | EP0956304A1 Dendritic cell-specific antibodies |
| 11/17/1999 | EP0956298A1 Snrnp sm proteins |
| 11/17/1999 | EP0956286A1 Synthesis of terfenadine and derivatives |
| 11/17/1999 | EP0956042A2 Mycosis vaccines |
| 11/17/1999 | EP0956040A1 Stimulation of host defense mechanisms against viral challenges |
| 11/17/1999 | EP0956035A1 Oral cyclosporin formulations |
| 11/17/1999 | EP0956034A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
| 11/17/1999 | EP0956033A1 Total synthesis of the amino hip analogue of didemnin a |
| 11/17/1999 | EP0956031A1 Inhibition of 26s and 20s proteasome by indanones |
| 11/17/1999 | EP0956021A1 L-$g(b)-DIOXOLANE URIDINE ANALOGS AND METHODS FOR TREATING AND PREVENTING VIRUS INFECTIONS |
| 11/17/1999 | EP0956014A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom |
| 11/17/1999 | EP0955808A1 Human g-protein coupled receptor |
| 11/17/1999 | CN1235609A Immunostimulatory nucleic acid molecules |